P738: Response to etrasimod treatment in ulcerative colitis is associated with a reduction of circulating B and pro-inflammatory T cells: a single-cell-based post-hoc sub-analysis of the ELEVATE UC 52 trialECCO'24Year: 2024
Authors: Weidinger, C.(1)*;Milek, M.(2);Hecker, J.(1);Haag, L.M.(1);Freise, I.(1);Obermayer, B.(2);Beule, D.(2);Ryan, R.D.(3);Crosby, C.(3);Siegmund, B.(1);
(1)Charité – Universitätsmedizin Berlin- corporate member of Freie Universität Berlin and Humboldt -Universität zu Berlin, Department of Gastroenterology- Infectious Diseases and Rheumatology, Berlin, Germany;(2)Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Core Unit Bioinformatics, Berlin, Germany;(3)Pfizer Inc., Pfizer Inc., La Jolla- CA, United States;
P739: Translating Pharmacokinetic and Efficacy Outcomes of NLRX1 Agonist NX-13: Contrasting a Pig Model and a Human Phase 1b Clinical Trial in Ulcerative ColitisECCO'24Year: 2024
Authors: Siegmund, B.(1)*;Verstockt, B.(2);Dubinsky, M.(3);Mosig, R.(4);Cataldi, F.(5);Danese, S.(6);Yarur, A.(7);
(1)Charité - Universitätsmedizin Berlin- corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Division of Gastroenterology, Berlin, Germany;(2)University Hospitals Leuven- KU Leuven-, Department of Gastroenterology and Hepatology- Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)Mount Sinai Kravis Children@E@s Hospital- Icahn School of Medicine Mount Sinai, Division of Pediatric Gastroenterology and Nutrition, New York, United States;(4)Landos Biopharma- Inc, Corporate Development, Blacksburg, United States;(5)Landos Biopharma- Inc, Clinical, Boston, United States;(6)IRCCS San Raffaele Scientific Institute- Vita-Salute San Raffaele University, Gastroenterology and Gastrointestinal Endoscopy Unit, Milan, Italy;(7)Cedars Sinai Medical Center, Division of Gastroenterology and Hepatology- Center for Inflammatory Bowel Diseases, Los Angeles, United States;
P740: Results at 52 weeks of Intravenous Ustekinumab as Maintenance Treatment in Patients with Loss of Response to Subcutaneous Doses: A Multicenter Retrospective Observational Study.ECCO'24Year: 2024
Authors: Valdés Delgado, T.(1);González Antuña, J.(1)*;Javier Rodriguez González, F.(2);Gutierrez Martinez, F.(2);Maldonado Pérez, B.(1);Castro Laria, L.(1);Belvis Jiménez, M.(1);Caunedo Álvarez, Á.(1);Alcain Martinez, G.(2);Camargo Camero, R.(2);Martos Van Dussen , J.V.(2);Fernández Castañer, A.(2);Argüelles-Arias, F.(1);
(1)Virgen Macarena University Hospital, Gastroenterology Department, Seville, Spain;(2)Virgen de la Victoria University Hospital, Gastroenterology Department, Malaga, Spain;
P741: Characterisation of endoscopic improvements with risankizumab treatment in patients with moderately to severely active Crohn’s diseaseECCO'24Year: 2024
Authors: Reinisch, W.(1)*;Colombel, J.F.(2);Ma, C.(3);Long, M.(4);Irving, P.M.(5);O@E@Brien, D.(6);Kligys, K.(6);Song, A.(6);Zhang, Y.(6);D’Haens, G.(7);
(1)Medical University Vienna, Department of Gastroenterology and Hepatology, Vienna, Austria;(2)Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York, United States;(3)University of Calgary, Division of Gastroenterology and Hepatology, Calgary, Canada;(4)University of North Carolina, Center for Gastrointestinal Biology and Disease- Division of Gastroenterology and Hepatology, Chapel Hill, United States;(5)Guy@E@s and St Thomas@E@ NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom;(6)AbbVie Inc., Research and Development, North Chicago, United States;(7)Amsterdam University Medical Centers, Department of Gastroenterology, Amsterdam, The Netherlands;
P742: The efficacy of comprehensive multivitamin and mineral supplement to treat symptoms of fatigue in patients with Inflammatory Bowel Disease in remission with immunomodulators and or biological agents.ECCO'24Year: 2024
Authors: Laheij, R.(1)*;Bierens-Peters, D.(1);Bruin, K.(1);Lutgens, M.(1);Sikkema, M.(1);de Wit, U.(1);Laheij, R.(1);
(1)Elisabeth-Tweesteden Hospital, Department of Gastroenterology and Hepatology, Tilburg, The Netherlands;
P743: A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitisECCO'24Year: 2024
Authors: Croft, A.(1,2,3)*;Okano, S.(4);Hartel, G.(4);Lord, A.(3);Walker, G.(1,2,3);Radford-Smith, G.(1,2,3);
(1)Royal Brisbane and Women@E@s Hospital, Department of Gastroenterology and Hepatology, Brisbane, Australia;(2)University of Queensland, Faculty of Medicine, Brisbane, Australia;(3)QIMR-Berghofer MRI, Gut Health Group, Brisbane, Australia;(4)QIMR-Berghofer MRI, Biostatistics, Brisbane, Australia;
P744: Evaluation of a lifestyle program based on physical activity on quality of life and fatigue in patients with Inflammatory Bowel Disease: a pilot studyECCO'24Year: 2024
Authors: Van De Pol, N.(1)*;Visser, E.H.(2);van der Woude, C.J.(1);de Vries, A.C.(1);de Jonge, V.(3);West, R.L.(2);
(1)Erasmus University Medical Center, Gastroenterology and hepatology, Rotterdam, The Netherlands;(2)Franciscus Gasthuis & Vlietland, Gastroenterology and hepatology, Rotterdam, The Netherlands;(3)Albert Schweitzer Hospital, Gastroenterology and hepatology, Dordrecht, The Netherlands;
P745: Assessment of Crohn’s disease patients following risankizumab initiation using intestinal ultrasound: A prospective studyECCO'24Year: 2024
Authors: Rosentreter , R.(1);Ingram , R.(1);Ma , C.(1);Chan , M.(1);Shukla , T.(1);Devlin , S.(1);Kaplan , G.(1);Seow , C.(1);Panaccione , R.(1);Novak , K.(1);Lu , C.(1)*;
(1)University of Calgary, Division or Gastroenterology and Hepatology- Department of Medicine, Calgary, Canada;
P746: Real-world Effectiveness and Safety of Advanced Combination Therapy in Patients with Inflammatory Bowel Disease: A Multi-center Brazilian Study.ECCO'24Year: 2024
Authors: Feitosa, F.C.(1);Queiroz, N.S.F.(2);Parra, R.S.(3);Azevedo, M.F.C.D.(4)*;Schiavetti , B.L.P.(5);Flores, C.(6);Fróes, R.D.S.B.(7);Boarini , L.R.(8);Boratto , S.D.F.(9);Junior, A.J.T.A.(10);Junior, N.L.T.G.(11);Nóbrega, F.J.F.(12);Teixeira, E.F.L.(13);Rzetelna, H.(14); Damião, A.O.M.C.(4);Motta , M.P.(15);Sassaki, L.Y.(16);Souza, H.S.P.D.(17);Luporini, R.L.(18);Ferreira , S.D.C.F.(19);Chebli, L.A.(20);Chebli, J.M.F.(20);
(1)Aliança Hospital- Rede d@E@Or São Luiz, Gastroenterology, Salvador, Brazil;(2)Health Sciences Graduate Program- Pontifícia Universidade Católica do Paraná PUCPR- Curitiba- Brazil 2. IBD outpatients clinic- Santa Cruz Hospital- Curitiba- Brazil, Gastroenterology, Curitiba, Brazil;(3)Ribeirão Preto Medical School University of São Paulo, Surgery, Ribeirão Preto, Brazil;(4)University of São Paulo School of Medicine, Gastroenterology, São Paulo, Brazil;(5)Inflammatory Bowel Diseases Outpatient Clinic, Gastroenterology, Santos, Brazil;(6)Inflammatory Bowel Disease Center, Gastroenterology, Porto Alegre, Brazil;(7)Department of Gastroenterology and Endoscopy- Gastromed, Gastroenterology, Rio de Janeiro, Brazil;(8)Inflammatory Bowel Disease Center- São Luiz São Caetano Hospital, Gastroenterology, São Caetano, Brazil;(9)Departament of General Surgery- Medical School- FMABC, Surgery, Santo André, Brazil;(10)Department of Surgery- Medical School- Pontificate Catholic University of Campinas PUC Campinas, Surgery, Campinas, Brazil;(11)Colonoscopy and colorectal Surgery Department of Inflammatory Bowel Diseases- Hospital Vivalle Rede DOr, Surgery, São José dos Campos, Brazil;(12)Department of Gastroenterology- Lauro Wanderley Hospital- Federal University of Paraíba, Gastroenterology, João Pessoa, Brazil;(13)Força Aérea do Galeão Hospital, Gastroenterology, Rio de Janeiro, Brazil;(14)1.General Hospital Santa Casa da Misericórdia do Rio de Janeiro/RJ 2. Departament Internal Medicine-Souza Marques Medicine School 3. University Estácio de Sá 4. Quinta D’Or Hospital, Gastroenterology, Rio de Janeiro, Brazil;(15)Hospital das Clínicas- Federal University of Bahia, Gastroenterology, Salvador, Brazil;(16)Department of Internal Medicine- Medical School- Sao Paulo State University UNESP, Internal Medicine, Botucatu, Brazil;(17)1. Department of Clinical Medicine- Federal University of Rio de Janeiro UFRJ 2. D’Or Institute for Research and Education IDOR, Clinical Medicine, Rio de Janeiro, Brazil;(18)1. Department of Medicine- Federal University of São Carlos- 2. Department of Surgery- Santa Casa of São Carlos- São Carlos, Medicine, São Carlos, Brazil;(19)Department of Clinical Medicine- Ribeirão Preto Medical School- University of São Paulo, Clinical Medicine, Ribeirão Preto, Brazil;(20)IBD Center- Federal University of Juiz de Fora, Gastroenterology, Juiz de Fora, Brazil;
P747: Assessment of a microlearning programme for patients with Inflammatory Bowel Disease (The ADEII project) on ansiety/depression status and illness perception.ECCO'24Year: 2024
Authors: De Castro Parga, M.L.(1,2)*;Hernández, V.(1,2);Sanromán, L.(1,2);Martínez-Cadilla, J.(1,2);Figueira, M.(1,2);Rodriguez-Prada, I.(1,2);
(1)Hospital Alvaro Cunqueiro CHUVI, Department of Gastroenterology, Vigo, Spain;(2)Galicia Sur Health Research Institute IIS Galicia Sur. SERGAS-UVIGO., Gastroenterology Research Group, Vigo, Spain;
P748: Place of thiopurine monotherapy in the treatment of Crohn@E@s Disease in the era of biologic therapies: results of a long-term tertiary single-center experienceECCO'24Year: 2024
Authors: Aouroud, H.(1)*;Aouroud, M.(1);Lairani, F.E.(1);Nacir, O.(1);Ait errami, A.(1);Oubaha, S.(1);Samlani, Z.(1);Krati, K.(1);
(1)Mohamed VI UNIVERSITY HOSPITAL, Gastro-enterology, Marrakech, Morocco;
P749: Comparison of bowel preparations for colonoscopy in inflammatory bowel disease- A systematic review and network meta-analysis of randomized trialsECCO'24Year: 2024
Authors: Chatterjee, A.(1);Kaur, S.(1);Jena, A.(2);Patil, A.(3);Dutta, U.(1);Sebastian, S.(4);Sharma, V.(5)*;
(1)PGIMER, Gastroenterology, Chandigarh, India;(2)SUM Hospital, Gastroenterology, Bhubhaneshwar, India;(3)PGIMER, Pharmacology, Chandigarh, India;(4)Hull University Teaching Hospitals NHS Trust, IBD Unit, Hull, United Kingdom;(5)Postgraduate Institute of Medical Education and Research, Gastroenterology, Chandigarh, India;
P750: Endoscopic balloon dilation associated with biological therapy in Crohn@E@s Disease strictures: a single center experience.ECCO'24Year: 2024
Authors: Lopetuso, L.R.(1);Coppola, G.(2)*;Alfieri, N.(1);Morretta, C.(1);Di Vincenzo, F.(1);Puca, P.(1);Parisio, L.(1);Marmo, C.(3);Settanni, C.R.(4);Laterza, L.(1);Pugliese, D.(1);Riccioni, M.E.(3);Cammarota, G.(5);Papa, A.(6);Gasbarrini, A.(5);Scaldaferri, F.(1);
(1)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IBD Unit - CEMAD, Rome, Italy;(2)IRCSS Fondazione Policlinico Universitario A. Gemelli, IBD Unit - CEMAD, Rome, Italy;(3)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Endoscopia Digestiva Chirurgica, Rome, Italy;(4)IRCCS Istituto di Ricovero e Cura a Carattere Scientifico, UOSD Gastroenterologia ed Endoscopia Digestiva, Ancona, Italy;(5)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Internal Medicine and Gastroenterology, Rome, Italy;(6)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Day Hospital of Gastroenterology, Rome, Italy;
P751: Off-label dose escalation of Ustekinumab in Inflammatory Bowel Disease patients. Safety profil of different patterns.ECCO'24Year: 2024
Authors: García-Morales, N.(1,2);Agra-Blanco, I.(3);Gayoso-Rey, M.(3);Carmona, A.(4);Ayude, M.(1,5);De Castro Parga, M.L.(1,2)*;Rodriguez-Prada, I.(1,2);
(1)Hospital Alvaro Cunqueiro CHUVI, Department of Gastroenterology, Vigo, Spain;(2)Galicia Sur Health Research Institute IIS Galicia Sur. SERGAS-UVIGO., Gastroenterology Research Group, Vigo, Spain;(3)Hospital Alvaro Cunqueiro CHUVI, Department of Pharmacy, Vigo, Spain;(4)Hospital Ribera-POVISA, Department of Gastroenterology, Vigo, Spain;(5)Galicia Sur Health Research Institute IIS Galicia Sur. SERGAS-UVIGO., Department of Gastroenterology, Vigo, Spain;
P752: Difficult-to-treat inflammatory bowel disease: effectiveness and safety of 4th and 5th linesECCO'24Year: 2024
Authors: Caron, B.(1)*;Habert, A.(1);Bonsack, O.(1);Camara, H.(2);Jeanbert, E.(2);Parigi, T.L.(3);Netter, P.(4);Danese, S.(3);Peyrin-Biroulet, L.(1);
(1)Nancy University Hospital, Gastroenterology, Nancy, France;(2)Nancy University Hospital, Methodology- data management and statistic, Nancy, France;(3)IRCCS Ospedale San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(4)University of Lorraine, Ingénierie Moléculaire et Ingénierie Articulaire IMoPA- UMR-7365 CNRS, Vandoeuvre les Nancy, France;
P753: Early perianal abscess recurrence in patients with perianal Crohn@E@s disease on biologic therapy predicts long-term permanent fecal diversionECCO'24Year: 2024
Authors: Yokoo, T.(1)*;Yoshikawa, S.(1);Tsutomu, M.(1);Terauchi, S.(1);Uchida, H.(1);Nakao, T.(1);Yamaoka, K.(1);Inagaki, M.(1);Tani, T.(1);Okamoto, K.(1);Inatsugi, N.(1);
(1)Kenseikai Dongo hospital, Nara Coloproctology center, Yamatotakada city, Japan;
P754: Inadequate Pregnancy Specific Knowledge among Patients with Inflammatory Bowel Disease: A Multi-Center Survey in ChinaECCO'24Year: 2024
Authors: Li, R.(1)*;Wu, T.(2);Li, X.(1);Zhou, H.(1);Shi, Y.(3);Wang, F.(1);Liang, J.(4);
(1)Air Force Military Medical University, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xi@E@an, China;(2)Xijing Hospital of Digestive Diseases, State key Laboratory of Cancer Biology- National Clinical Research Center for Digestive Diseases, Xian, China;(3)Xijing Hospital of Digestive Diseases, State key Laboratory of Cancer Biology- National Clinical Research Center for Digestive Diseases, Xi@E@an, China;(4)Xijing Hospital of Digestive Diseases, State key Laboratory of Cancer Biology- National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xian, China;
P756: Efficacy and safety of medical therapies for maintenance of surgically induced remission in Crohn’s disease: A systematic review and network meta-analysisECCO'24Year: 2024
Authors: Sinopoulou, V.(1);Gordon, M.(1);Vuyyuru, S.(2)*;Darie, A.M.(3);Limdi, J.(4);Moran, G.(5);
(1)University of Central Lancashire, School of Medicine and Dentistry, Preston, United Kingdom;(2)Nottingham University Hospitals NHS trust, Gastroenterology, Nottingham, United Kingdom;(3)Nottingham University Hospitals NHS trust- Nottingham- UK, Gastroenterology, Nottingham, United Kingdom;(4)Northern Care Alliance NHS Foundation Trust- Manchester- UK, Department of Gastroenterology, Manchester, United Kingdom;(5)Nottingham University Hospitals NHS trust- Nottingham- UK- Nottingham NIHR Biomedical Research Centre- Nottingham- UK- Translational medical sciences- School of Medicine- Faculty of Medicine and Health science- University of Nottingham- UK, Gastroenterology, Nottingham, United Kingdom;
